ArticleCancer biology & therapy2008

Application of doxorubicin-induced rAAV2-p53 gene delivery in combined chemotherapy and gene therapy for hepatocellular carcinoma.

Chun-Ann Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.